PFIZER INC Assets Held-for-sale, Long Lived, Fair Value Disclosure
PFIZER INC (PFE) had Assets Held-for-sale, Long Lived, Fair Value Disclosure of $112.00 million as of 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure · last filed 2014-02-28
- 2013-12-31: Assets Held-for-sale, Long Lived, Fair Value Disclosure $112.00M.
- 2013-09-29: Assets Held-for-sale, Long Lived, Fair Value Disclosure $82.00M.
- 2013-06-30: Assets Held-for-sale, Long Lived, Fair Value Disclosure $82.00M.
- 2013-03-31: Assets Held-for-sale, Long Lived, Fair Value Disclosure $82.00M.
| Period end | Assets Held-for-sale, Long Lived, Fair Value Disclosure |
|---|---|
| 2013-12-31 | $112.00M 10-K · filed 2014-02-28 |
| 2013-09-29 | $82.00M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $82.00M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $82.00M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $136.00M 10-K · filed 2013-02-28 |
| 2012-09-30 | $94.00M 10-Q · filed 2012-11-09 |
| 2012-07-01 | $97.00M 10-Q · filed 2012-08-09 |
| 2012-04-01 | $110.00M 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |